• DRAMP ID

    • DRAMP29953
    • Peptide Name

    • 17BIPHE2
    • Source

    • Synthetic construct(derived from LL-37)
    • Family

    • Filoviridae
    • Gene

    • Not found
    • Sequence

    • GXKRlVQRlKDXlRNLV
    • Sequence Length

    • 17
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Not found
    • Biological Activity

    • Antimicrobial, Antiviral
    • Target Organism

      • [Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.71 µM);inhibition of viral infection in primary macrophages(IC50=5.6 µM).
    • Hemolytic Activity

      • No hemolysis information or data found in the reference(s) presented in this entry
    • Cytotoxicity

      • No cytotoxicity information or data found in the reference(s) presented in this entry
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • The 'X' at position 2 and 12 indicates biphenylalanine.
    • Stereochemistry

    • Mixed(D-Leu5, 9, 13)
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP29953 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP29953.
    • Formula

    • C61H103N25O12
    • Absent Amino Acids

    • ACEFHIMPSTWY
    • Common Amino Acids

    • R
    • Mass

    • 2030.86
    • PI

    • 11.72
    • Basic Residues

    • 5
    • Acidic Residues

    • 1
    • Hydrophobic Residues

    • 3
    • Net Charge

    • +4
    • Boman Index

    • -6282
    • Hydrophobicity

    • -1.177
    • Aliphatic Index

    • 57.06
    • Half Life

      • Mammalian:30 hour
      • Yeast:>20 hour
      • E.coli:>10 hour
    • Extinction Coefficient Cystines

    • 0
    • Absorbance 280nm

    • 0
    • Polar Residues

    • 2

DRAMP29953

    • Mechanism

    • Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.
  • ·Literature 1
    • Title

    • Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.
    • Reference

    • iScience. 2020 Apr 24;23(4):100999.
    • Author

    • Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.